SARAH J GRETEMAN
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant OMAHA, NE NPI 1962949917
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant NE ABBVIE INC. All categories
General Payments — all program years on this page
$23,558.73
- Category: General Payments
- Program years: PY2021–2023
- Record count: 559
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $1,225.79 across 53 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $925.79 | 51 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $300.00 | 2 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $464.82 | 15 |
| Lundbeck LLC | $88.67 | 3 |
| Biogen, Inc. | $62.60 | 3 |
| Celgene Corporation | $50.26 | 3 |
| GENZYME CORPORATION | $43.43 | 2 |
| Ipsen Biopharmaceuticals, Inc | $42.98 | 2 |
| Lilly USA, LLC | $40.72 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $30.31 | 2 |
| Amneal Pharmaceuticals LLC | $27.45 | 1 |
| UCB, Inc. | $24.51 | 1 |
| BANNER LIFE SCIENCES, LLC | $23.99 | 1 |
| CSL Behring | $23.88 | 1 |
| Amgen Inc. | $22.83 | 1 |
| ARGENX US, INC. | $22.12 | 1 |
| UPSHER-SMITH LABORATORIES LLC | $21.92 | 1 |
| Teva Pharmaceuticals USA, Inc. | $21.31 | 1 |
| Kyowa Kirin, Inc. | $20.90 | 1 |
| Neurocrine BioSciences, Inc. | $20.41 | 1 |
| EISAI INC. | $19.28 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $18.34 | 1 |
| Axsome Therapeutics, Inc. | $18.31 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.19 | 1 |
| Merz Pharmaceuticals, LLC | $17.67 | 1 |
| Mallinckrodt Hospital Products Inc. | $17.24 | 1 |
| HARMONY BIOSCIENCES LLC | $17.05 | 1 |
| PFIZER INC. | $16.95 | 1 |
| IMPEL PHARMACEUTICALS INC. | $16.43 | 1 |
| SK Life Science, Inc. | $13.22 | 1 |
By program year
Records — PY2023 (53)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.